Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Age of cataract extraction in post-refractive surgery patients.

Moshirfar M, Ostler EM, Smedley JG, Mamalis N, Muthappan V.

J Cataract Refract Surg. 2014 May;40(5):841-2. doi: 10.1016/j.jcrs.2014.03.001. No abstract available.


Rate of ectasia and incidence of irregular topography in patients with unidentified preoperative risk factors undergoing femtosecond laser-assisted LASIK.

Moshirfar M, Smedley JG, Muthappan V, Jarsted A, Ostler EM.

Clin Ophthalmol. 2014;8:35-42. doi: 10.2147/OPTH.S53370. Epub 2013 Dec 10.


Cysteine-scanning mutagenesis supports the importance of Clostridium perfringens enterotoxin amino acids 80 to 106 for membrane insertion and pore formation.

Chen J, Theoret JR, Shrestha A, Smedley JG 3rd, McClane BA.

Infect Immun. 2012 Dec;80(12):4078-88. doi: 10.1128/IAI.00069-12. Epub 2012 Sep 10.


Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins.

Briggs DC, Naylor CE, Smedley JG 3rd, Lukoyanova N, Robertson S, Moss DS, McClane BA, Basak AK.

J Mol Biol. 2011 Oct 14;413(1):138-49. doi: 10.1016/j.jmb.2011.07.066. Epub 2011 Aug 3.


Crystallization and preliminary crystallographic analysis of the Clostridium perfringens enterotoxin.

Briggs DC, Smedley JG 3rd, McClane BA, Basak AK.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Jul 1;66(Pt 7):794-7. doi: 10.1107/S1744309110016507. Epub 2010 Jun 24.


Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin.

Robertson SL, Smedley JG 3rd, McClane BA.

Infect Immun. 2010 Jan;78(1):505-17. doi: 10.1128/IAI.00778-09. Epub 2009 Nov 2.


Probing the pH-dependent prepore to pore transition of Bacillus anthracis protective antigen with differential oxidative protein footprinting.

Smedley JG 3rd, Sharp JS, Kuhn JF, Tomer KB.

Biochemistry. 2008 Oct 7;47(40):10694-704. doi: 10.1021/bi800533t. Epub 2008 Sep 12.


Noncytotoxic Clostridium perfringens enterotoxin (CPE) variants localize CPE intestinal binding and demonstrate a relationship between CPE-induced cytotoxicity and enterotoxicity.

Smedley JG 3rd, Saputo J, Parker JC, Fernandez-Miyakawa ME, Robertson SL, McClane BA, Uzal FA.

Infect Immun. 2008 Aug;76(8):3793-800. doi: 10.1128/IAI.00460-08. Epub 2008 May 27.


Structure of the claudin-binding domain of Clostridium perfringens enterotoxin.

Van Itallie CM, Betts L, Smedley JG 3rd, McClane BA, Anderson JM.

J Biol Chem. 2008 Jan 4;283(1):268-74. Epub 2007 Oct 31.


Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis.

Kominsky SL, Tyler B, Sosnowski J, Brady K, Doucet M, Nell D, Smedley JG 3rd, McClane B, Brem H, Sukumar S.

Cancer Res. 2007 Sep 1;67(17):7977-82.


Compositional and stoichiometric analysis of Clostridium perfringens enterotoxin complexes in Caco-2 cells and claudin 4 fibroblast transfectants.

Robertson SL, Smedley JG 3rd, Singh U, Chakrabarti G, Van Itallie CM, Anderson JM, McClane BA.

Cell Microbiol. 2007 Nov;9(11):2734-55. Epub 2007 Jun 24.


Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin.

Litkouhi B, Kwong J, Lo CM, Smedley JG 3rd, McClane BA, Aponte M, Gao Z, Sarno JL, Hinners J, Welch WR, Berkowitz RS, Mok SC, Garner EI.

Neoplasia. 2007 Apr;9(4):304-14.


Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin.

Smedley JG 3rd, Uzal FA, McClane BA.

Infect Immun. 2007 May;75(5):2381-90. Epub 2007 Feb 16.


Influence of pilin glycosylation on Pseudomonas aeruginosa 1244 pilus function.

Smedley JG 3rd, Jewell E, Roguskie J, Horzempa J, Syboldt A, Stolz DB, Castric P.

Infect Immun. 2005 Dec;73(12):7922-31.


The enteric toxins of Clostridium perfringens.

Smedley JG 3rd, Fisher DJ, Sayeed S, Chakrabarti G, McClane BA.

Rev Physiol Biochem Pharmacol. 2004;152:183-204. Epub 2004 Oct 23. Review.


Supplemental Content

Loading ...
Support Center